Aresus Pharma GmbH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis (NCT07137819) | Aresus Pharma GmbH | 2024-09-04 |
Track Aresus Pharma GmbH automatically
Every clearance here is in the API, with alerts when new ones post.